Research
Endocrinology
GenSci has dedicated its significant R&D efforts to endocrinology and related areas. GenSci has accumulated a considerable amount of knowledge and experience in the science of endocrinology through its years of success manufacturing and marketing Jintropin somatropin. Furthermore, GenSci has realized the importance of endocrinology products in improving the healthcare needs in China. GenSci will utilize its strength and expertise in the area to expand its scientific exploration.
Pediatrics
Pediatrics research at GenSci has been closely-related its flagship product, Jintropin, in treating growth hormone deficiency (GDH) in children. Improving children health is the top one of GenSci's obligations. GenSci's long-acting somatropin, PEG-GH, which is in Phase II, will bring great convenience and efficacy to pediatric patients.
Other related areas
GenSci has focused on its product pipeline of protein therapeutics by recombinant DNA technology. With its patented E.coli secretion expression system, investigation programs at GenSci cover more protein molecules in the areas of wound healing, infertility and hepatitis.
